Hemoptysis from Complex Pulmonary Aspergilloma Treated by Cavernostomy and Thoracoplasty

Giang, Nguyen Truong; Dũng, Nguyên Tiến; Hien, Nguyen Thanh; Thiet, Truong Thanh; Hiep, Phan Sy; Vu, Nguyen The; Pho, Dinh Cong; Định, Nguyễn Văn; Hung, Pham Ngoc

doi:10.21203/rs.2.12232/v2

Cited by 5 publications

(4 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, wedge resection should be considered as a definitive treatment in massive or recurrent hemoptysis patients who can be operable [42]. Cavernostomy and thoracoplasty were also determined the safety and efficacy for high-risk patients with aspergilloma [43].…”

Section: Discussionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Phạm

et al. 2020

BMC Pulm Med

View full text Add to dashboard Cite

Background: Multidetector computed tomography (MDCT) angiography is a useful examination to detect the source of the bleeding in patients with hemoptysis. The aim of the study was to prospectively evaluate the role and clinical efficacy of MDCT angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence. Methods: It is a double-center study which included 57 hemoptysis patients undergoing MDCT angiography prior to BAE from August 2019 to July 2020. A prospective analysis of culprit arteries detected by MDCT angiography allowed an evaluation of the role of this technique. A follow-up was done to assess the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis. Results: The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 ± 1.73. Among which, the average numbers of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 ± 0.41 and 1.04 ± 1.57, respectively. The immediate clinical success rate, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7, 18.5, 16.7%, respectively. Aspergilloma (HR = 6.63, 95% CI: 1.31-33.60, p = 0.022) was associated with an increase in the risk of early recurrence. Conclusions: MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

show abstract

Section: Discussionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Phạm

et al. 2020

BMC Pulm Med

View full text Add to dashboard Cite

show abstract

“…Therefore, wedge resection should be considered as a de nitive treatment in massive or recurrent hemoptysis patients who can be operable [42]. Cavernostomy and thoracoplasty were also determined the safety and e cacy for high-risk patients with aspergilloma [43].…”

Section: Discussionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Le¹,

Phạm

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Multidetector computed tomography (MDCT) angiography is an useful examination to detect the source of the bleeding in patients with hemoptysis. The aim of the study was to prospectively evaluate the role and clinical efficacy of MDCT angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods: It is a double-center study which included 57 hemoptysis patients undergoing MDCT angiography prior to BAE from August 2019 to July 2020. A prospective analysis of culprit arteries detected by MDCT angiography allowed an evaluation of the role of this technique. A follow-up was done to assess the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results: The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 1.73. Among which, the average numbers of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 0.41 and 1.04 1.57, respectively. The immediate clinical success rate, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR = 6.63, 95% CI: 1.31-33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions: MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

show abstract

“…Therefore, wedge resection should be considered as a de nitive treatment in massive or recurrent hemoptysis patients who can be operable [37]. Cavernostomy and thoracoplasty were also determined the safety and e cacy for high-risk patients with aspergilloma [38].…”

Section: Discussionmentioning

confidence: 99%

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Le¹,

Le²,

Pham³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background To prospective evaluate the role and clinical efficacy of multidetector computed tomography (MDCT) angiography before bronchial artery embolization (BAE) for the management of hemoptysis, and to investigate the predictors of early recurrence.Methods From August 2019 to July 2020, a double-center study of 57 patients with hemoptysis referred for BAE underwent MDCT angiography before. A prospective analysis of culprit arteries detected by MDCT angiography allowed evaluation of the role of this technique. Follow-up was done for assessment of the efficacy of BAE with preprocedural MDCT angiography and to explore the risk factors of early recurrent hemoptysis.Results The accuracy of MDCT angiography in the identification of culprit arteries was as high as 97.5%. The average number of total culprit arteries per patient was 2.75 \(\pm\) 1.73, among them the average number of culprit ectopic bronchial arteries (BAs) and non-bronchial systemic arteries (NBSAs) per patient were 0.21 \(\pm\) 0.41 and 1.04 \(\pm\) 1.57, respectively. The immediate clinical success, total hemoptysis recurrence rate, and early hemoptysis recurrence rate of BAE following MDCT angiography were 94.7%, 18.5%, 16.7%, respectively. Aspergilloma (HR 6.63, 95% CI 1.31–33.60, p = 0.022) was associated with an increase in the risk of early recurrence.Conclusions MDCT angiography should be performed before BAE for the management of hemoptysis. Aspergilloma was an independent predictor for early recurrence.

show abstract

Hemoptysis from Complex Pulmonary Aspergilloma Treated by Cavernostomy and Thoracoplasty

Cited by 5 publications

References 36 publications

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Value of multidetector computed tomography angiography before bronchial artery embolization in hemoptysis management and early recurrence prediction: a prospective study

Contact Info

Product

Resources

About